REQUEST A DEMO
Total
USD $0.00
Search more companies

Swixx Biopharma Sp. z o.o. (Poland)

Main Activities: Marketing Research and Public Opinion Polling
Secondary Activities: Administrative Management and General Management Consulting Services | Advertising, Public Relations, and Related Services | All Other Professional, Scientific, and Technical Services
Full name: Swixx Biopharma Sp. z o.o. Profile Updated: May 08, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Swixx Biopharma Sp. z o.o. is a company in Poland, with a head office in Warsaw. It operates in the Marketing Research and Public Opinion Polling sector. Swixx Biopharma Sp. z o.o. was incorporated on September 21, 2018. There was a net sales revenue increase of 40.81% reported in Swixx Biopharma Sp. z o.o.’s latest financial highlights for 2023. Over the same period, its total assets grew by 68.16%. The net profit margin of Swixx Biopharma Sp. z o.o. increased by 1.48% in 2023.

Headquarters
Ul. Prosta 51
Warsaw; Mazowieckie; Postal Code: 00-838

Contact Details: Purchase the Swixx Biopharma Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Swixx Biopharma Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Swixx Biopharma Sp. z o.o. report to view the information.
Incorporation Date:
September 21, 2018
Key Executives
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Proxy
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Swixx Biopharma Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
40.81%
Total operating revenue
40.75%
Operating profit (EBIT)
41.04%
EBITDA
48.19%
Net Profit (Loss) for the Period
86.84%
Total assets
68.16%
Total equity
104.67%
Operating Profit Margin (ROS)
0.01%
Net Profit Margin
1.48%
Return on Equity (ROE)
-4.88%
Debt to Equity Ratio
0.35%
Quick Ratio
-0.01%
Cash Ratio
-0.2%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?